Fibrillary glomerulopathy.
Brady HR.
Kidney Int. 1998 May;53(5):1421-9. doi: 10.1046/j.1523-1755.1998.t01-1-00094.x.
[Latest updates on immunotactoid glomerulopathy and fibrillary glomerulonephritis].
Lafargue MC, Cohen C.
Bull Cancer. 2024 Jul-Aug;111(7-8):741-747. doi: 10.1016/j.bulcan.2022.12.014. Epub 2023 Feb 15.
[Fibrillary glomerulopathy].
Kovác A, Slugen I, Danis D, Demes M, Kollárová M, Kohn R, Podoba J, Goncalvesová E.
Vnitr Lek. 1997 Oct;43(10):691-5.
Fibrillary glomerulonephritis and immunotactoid glomerulopathy.
Ivanyi B, Degrell P.
Nephrol Dial Transplant. 2004 Sep;19(9):2166-70. doi: 10.1093/ndt/gfh376.
Paraprotein-Mediated Glomerular Diseases.
Miao J, Herrmann SM, Obaidi Z, Caza T, Bonilla M.
Adv Kidney Dis Health. 2024 Jul;31(4):358-373. doi: 10.1053/j.akdh.2024.02.005.
Glomerulopathies with Fibrillary Deposits.
Dzekova-Vidimliski P, Karanfilovski V, Nikolov IG, Rambabova-Bushljetik I, Ristovska V, Petrushevska G, Selim G.
Pril (Makedon Akad Nauk Umet Odd Med Nauki). 2023 Jul 15;44(2):99-106. doi: 10.2478/prilozi-2023-0030. Print 2023 Jul 1.
Standardized classification and reporting of glomerulonephritis.
Sethi S, Fervenza FC.
Nephrol Dial Transplant. 2019 Feb 1;34(2):193-199. doi: 10.1093/ndt/gfy220.
Updates on the Diagnosis and Management of Fibrillary Glomerulonephritis.
Attieh RM, Yang Y, Rosenstock JL.
Adv Kidney Dis Health. 2024 Jul;31(4):374-383. doi: 10.1053/j.akdh.2024.03.006.
[Immunotactoid glomerulopathy].
Wang S, Zhang Y, Zou W.
Zhonghua Yi Xue Za Zhi. 1996 Sep;76(9):688-90.
Clinical features, predictors of disease progression and results of renal transplantation in fibrillary/immunotactoid glomerulopathy.
Pronovost PH, Brady HR, Gunning ME, Espinoza O, Rennke HG.
Nephrol Dial Transplant. 1996 May;11(5):837-42. doi: 10.1093/oxfordjournals.ndt.a027409.
